What are the symptoms of Von Hippel-Lindau (VHL) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Von Hippel-Lindau (VHL) Disease

Von Hippel-Lindau disease is often asymptomatic in early stages, but manifests through symptoms related to tumor development in multiple organ systems, with ocular and neurological symptoms being among the earliest presentations. 1, 2

Ocular Manifestations

Retinal hemangioblastomas are frequently the first manifestation and can appear as early as the first year of life. 2

Early-Stage Ocular Symptoms

  • Most retinal hemangioblastomas are asymptomatic initially, which is why surveillance screening is critical rather than waiting for symptoms 1
  • Vision changes may not occur until complications develop 1

Advanced Ocular Symptoms (When Complications Arise)

  • Vision loss occurs in approximately 20% of patients when retinal hemangioblastomas progress untreated 2, 3
  • Symptoms develop from tumor-associated exudation causing fibrosis, hemorrhage, or retinal detachment 1
  • Epiretinal membrane formation 1
  • Retinal vascular proliferation 1

Central Nervous System Symptoms

CNS hemangioblastomas occur in 60-80% of patients and cause symptoms through mass effect. 2, 4

  • Headaches from increased intracranial pressure 2
  • Ataxia and balance problems (cerebellar lesions) 2
  • Neurological deficits depending on tumor location (brain stem or spinal cord) 2, 5
  • The youngest documented CNS hemangioblastoma was diagnosed at age 9 years 2, 4

Renal Symptoms

Renal manifestations develop in up to 70% of patients and represent a leading cause of mortality. 2, 4

  • Most renal cysts and early renal cell carcinomas are asymptomatic 5, 6
  • Hematuria (blood in urine) in advanced cases 5
  • Flank pain when tumors become large 5
  • Abdominal mass (palpable in advanced disease) 5

Endocrine Symptoms (Pheochromocytoma)

Pheochromocytomas occur in 7-20% of families, associated with specific missense mutations. 2

  • Episodic hypertension 5, 6
  • Headaches 5
  • Palpitations 5
  • Excessive sweating 5
  • Anxiety or panic attacks 5

Inner Ear Symptoms

Endolymphatic sac tumors can cause auditory symptoms. 5, 6

  • Tinnitus (ringing in ears) 5
  • Progressive hearing loss or deafness 5, 6
  • Vertigo 6

Pancreatic Manifestations

Pancreatic neuroendocrine tumors and cysts develop but are often asymptomatic. 2, 5

  • Most pancreatic lesions are discovered on surveillance imaging rather than through symptoms 5, 6
  • Abdominal pain (when tumors become large) 6

Reproductive System Symptoms

  • Epididymal cystadenomas in males are typically asymptomatic 2, 5
  • Broad ligament cystadenomas in females are usually asymptomatic 2, 5

Critical Clinical Pitfalls

The asymptomatic nature of early VHL manifestations is the most dangerous pitfall—waiting for symptoms before screening leads to preventable morbidity and mortality. 2, 4

  • Do not rely on symptoms for diagnosis; retinal hemangioblastomas can develop in the first year of life before any symptoms appear 2
  • A single retinal or CNS hemangioblastoma at any age warrants immediate genetic testing, even without family history, as 20% of cases arise from de novo mutations 2, 4
  • Historical median life expectancy was only 49 years, but comprehensive surveillance has improved this to 60-67 years for those born in 2000, demonstrating the critical importance of early detection before symptoms develop 2, 3

Surveillance must begin within 12 months after birth and continue throughout life, regardless of symptom presence. 1, 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Von Hippel-Lindau Disease: Clinical Features and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Von Hippel-Lindau Disease Epidemiology and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Von Hippel-Lindau Syndrome in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.